Icon

TAUKLARIFY - (1-40mCi/ML; SOLUTION)

FLORQUINITAU F-18 CERVEAU LANTHEUS
1-40mCi/ML; SOLUTION
Less Than $1000 mn
None None
None None
None None
TAUKLARIFY is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being evaluated for Alzheimer’s disease to identify patients with tau neurofibrillary tangle (NFT) pathology.
Yes
TAUKLARIFY Patent 1 Patent 2
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.